Neurogram

About Neurogram

Neurogram develops an AI-driven platform that analyzes EEG data to identify neuro-biomarkers for neurological diseases, including epilepsy and Alzheimer's. This technology enhances diagnostic accuracy and reduces the time and costs associated with evaluating complex neurological conditions in critical care settings.

Neurogram develops an AI-driven platform that analyzes EEG data to identify neuro-biomarkers for neurological diseases, including epilepsy and Alzheimer's. This technology enhances diagnostic accuracy and reduces the time and costs associated with evaluating complex neurological conditions in critical care settings.

What does Neurogram do?

Neurogram develops an AI-driven platform that analyzes EEG data to identify neuro-biomarkers for neurological diseases, including epilepsy and Alzheimer's. This technology enhances diagnostic accuracy and reduces the time and costs associated with evaluating complex neurological conditions in critical care settings.

Where is Neurogram located?

Neurogram is based in Atlanta, United States.

When was Neurogram founded?

Neurogram was founded in 2021.

Location
Atlanta, United States
Founded
2021
Employees
15 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

Start Searching

Neurogram

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

Neurogram develops an AI-driven platform that analyzes EEG data to identify neuro-biomarkers for neurological diseases, including epilepsy and Alzheimer's. This technology enhances diagnostic accuracy and reduces the time and costs associated with evaluating complex neurological conditions in critical care settings.

neurogram.com700+
Founded 2021 – Atlanta, United States

Funding

No funding information available.

Team (15+)

No team information available.

Company Description

Neurogram develops an AI-driven platform that analyzes EEG data to identify neuro-biomarkers for neurological diseases, including epilepsy and Alzheimer's. This technology enhances diagnostic accuracy and reduces the time and costs associated with evaluating complex neurological conditions in critical care settings.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.